171 related articles for article (PubMed ID: 8393843)
1. Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma.
Yamashita K; Yonezawa S; Tanaka S; Shirahama H; Sakoda K; Imai K; Xing PX; McKenzie IF; Hilkens J; Kim YS
Int J Cancer; 1993 Aug; 55(1):82-91. PubMed ID: 8393843
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors.
Osako M; Yonezawa S; Siddiki B; Huang J; Ho JJ; Kim YS; Sato E
Cancer; 1993 Apr; 71(7):2191-9. PubMed ID: 8384065
[TBL] [Abstract][Full Text] [Related]
3. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
Yonezawa S; Sato E
Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors.
Tashiro Y; Yonezawa S; Kim YS; Sato E
Hum Pathol; 1994 Apr; 25(4):364-72. PubMed ID: 8163269
[TBL] [Abstract][Full Text] [Related]
5. Expression of mucin carbohydrates and core proteins in carcinomas of the ampulla of Vater: their relationship to prognosis.
Kitamura H; Yonezawa S; Tanaka S; Kim YS; Sato E
Jpn J Cancer Res; 1996 Jun; 87(6):631-40. PubMed ID: 8766528
[TBL] [Abstract][Full Text] [Related]
6. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis.
Tamada S; Goto M; Nomoto M; Nagata K; Shimizu T; Tanaka S; Sakoda K; Imai K; Yonezawa S
Pathol Int; 2002 Nov; 52(11):713-23. PubMed ID: 12685548
[TBL] [Abstract][Full Text] [Related]
7. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
[TBL] [Abstract][Full Text] [Related]
8. Mucosal dysplasia of the liver and the intraductal variant of peripheral cholangiocarcinoma in hepatolithiasis.
Ohta T; Nagakawa T; Ueda N; Nakamura T; Akiyama T; Ueno K; Miyazaki I
Cancer; 1991 Nov; 68(10):2217-23. PubMed ID: 1655206
[TBL] [Abstract][Full Text] [Related]
9. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
[TBL] [Abstract][Full Text] [Related]
10. Altered mucin gene expression in stone-containing intrahepatic bile ducts and cholangiocarcinomas.
Lee KT; Liu TS
Dig Dis Sci; 2001 Oct; 46(10):2166-72. PubMed ID: 11680592
[TBL] [Abstract][Full Text] [Related]
11. Mucin antigen expression in gastric carcinomas of young and old adults.
Sakamoto H; Yonezawa S; Utsunomiya T; Tanaka S; Kim YS; Sato E
Hum Pathol; 1997 Sep; 28(9):1056-65. PubMed ID: 9308730
[TBL] [Abstract][Full Text] [Related]
12. Expression of MUC1 and MUC2 and carbohydrate antigen Tn change during malignant transformation of biliary papillomatosis.
Amaya S; Sasaki M; Watanabe Y; Tsui WM; Tsuneyama K; Harada K; Nakanuma Y
Histopathology; 2001 Jun; 38(6):550-60. PubMed ID: 11422499
[TBL] [Abstract][Full Text] [Related]
13. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.
Park SY; Roh SJ; Kim YN; Kim SZ; Park HS; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
Oncol Rep; 2009 Sep; 22(3):649-57. PubMed ID: 19639217
[TBL] [Abstract][Full Text] [Related]
14. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis.
Zen Y; Sasaki M; Fujii T; Chen TC; Chen MF; Yeh TS; Jan YY; Huang SF; Nimura Y; Nakanuma Y
J Hepatol; 2006 Feb; 44(2):350-8. PubMed ID: 16360234
[TBL] [Abstract][Full Text] [Related]
15. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles.
Sasaki M; Nakanuma Y; Ho SB; Kim YS
Am J Clin Pathol; 1998 Mar; 109(3):302-8. PubMed ID: 9495202
[TBL] [Abstract][Full Text] [Related]
16. Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: an immunohistochemical study.
Sasaki M; Nakanuma Y; Kim YS
Hepatology; 1996 Nov; 24(5):1074-8. PubMed ID: 8903378
[TBL] [Abstract][Full Text] [Related]
17. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
[TBL] [Abstract][Full Text] [Related]
18. Expression of MUC1 and MUC2 mucins by human tumor cell lines.
Devine PL; Birrell GW; Whitehead RH; Harada H; Xing PX; McKenzie IF
Tumour Biol; 1992; 13(5-6):268-77. PubMed ID: 1283926
[TBL] [Abstract][Full Text] [Related]
19. The expression of MUC mucin in cholangiocarcinoma.
Mall AS; Tyler MG; Ho SB; Krige JE; Kahn D; Spearman W; Myer L; Govender D
Pathol Res Pract; 2010 Dec; 206(12):805-9. PubMed ID: 20947262
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen and blood group-related carbohydrate antigens in glycoproteins in human bile in hepatolithiasis. Japanese Study Group of Hepatolithiasis.
Sasaki M; Morita T; Hoso M; Nakanuma Y; Tanimura H
Hepatology; 1996 Feb; 23(2):258-63. PubMed ID: 8591850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
